Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MID-NET Cohort Study on Heart Failure Occurrence After TARLIGE (mirogabalin) and Other Neuropathic Pain Drugs
jRCT2031220177Recruiting
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of mirogabalin in Neuralgia (3 cohorts), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Occurrence of heart failure. Started Jan 2009; status: recruiting.
02
Drugs
mirogabalin
03
Conditions
Neuralgia
Beyond the preview
Go deeper on jRCT2031220177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220177.